Skip Nav Destination
1-7 of 7
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR)
Blood (1996) 87 (10): 4333–4339.
Efficient expression of functional human MDR1 gene in murine bone marrow after retroviral transduction of purified hematopoietic stem cells
Blood (1995) 86 (1): 111–121.
Recombinant immunotoxins containing anti-Tac(Fv) and derivatives of Pseudomonas exotoxin produce complete regression in mice of an interleukin-2 receptor-expressing human carcinoma
Blood (1994) 83 (2): 426–434.
E DelaFlor-Weiss, C Richardson, M Ward, A Himelstein, L Smith, S Podda, M Gottesman, I Pastan, A Bank
Blood (1992) 80 (12): 3106–3111.
Recombinant toxins containing the variable domains of the anti-Tac monoclonal antibody to the interleukin-2 receptor kill malignant cells from patients with chronic lymphocytic leukemia
Blood (1992) 80 (9): 2344–2352.
Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma
Blood (1992) 79 (7): 1775–1780.
Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice
GH Mickisch, I Aksentijevich, PV Schoenlein, LJ Goldstein, H Galski, C Stahle, DH Sachs, I Pastan, MM Gottesman
Blood (1992) 79 (4): 1087–1093.